Literature DB >> 6309190

DNA-DNA interstrand crosslinking by dimethyanesulphonic acid esters. Correlation with cytotoxicity and antitumour activity in the Yoshida lymphosarcoma model and relationship to chain length.

P Bedford, B W Fox.   

Abstract

Members of the homologous series of nine antitumour dimethanesulphonic acid esters, with the exception of ethylene dimethanesulphonate (EDMS), were found to cause DNA-DNA interstrand crosslinking in cells derived from the transplantable rodent Yoshida lymphosarcoma. The ability of the series to induce interstrand crosslinks was compared with in vitro cytotoxicity and in vivo antitumour activity and is discussed in relation to their chain length and ability to span critical target distances in DNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309190     DOI: 10.1016/0006-2952(83)90176-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters.

Authors:  J A Hartley; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde.

Authors:  P M O'Connor; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  DNA interstrand crosslinking and sequence selectivity of dimethanesulphonates.

Authors:  M Ponti; R L Souhami; B W Fox; J A Hartley
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

4.  A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).

Authors:  D B Smith; M J Lind; S B Kaye; E S Newlands; G R Blackledge; A Gibson
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

5.  Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.

Authors:  M Smellie; L R Kelland; D E Thurston; R L Souhami; J A Hartley
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

6.  Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.

Authors:  J D Down; A Boudewijn; J H Dillingh; B W Fox; R E Ploemacher
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.